Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul 10;13(14):2333.
doi: 10.3390/diagnostics13142333.

Beyond Visual Interpretation: Quantitative Analysis and Artificial Intelligence in Interstitial Lung Disease Diagnosis "Expanding Horizons in Radiology"

Affiliations
Review

Beyond Visual Interpretation: Quantitative Analysis and Artificial Intelligence in Interstitial Lung Disease Diagnosis "Expanding Horizons in Radiology"

Gaetano Rea et al. Diagnostics (Basel). .

Abstract

Diffuse lung disorders (DLDs) and interstitial lung diseases (ILDs) are pathological conditions affecting the lung parenchyma and interstitial network. There are approximately 200 different entities within this category. Radiologists play an increasingly important role in diagnosing and monitoring ILDs, as they can provide non-invasive, rapid, and repeatable assessments using high-resolution computed tomography (HRCT). HRCT offers a detailed view of the lung parenchyma, resembling a low-magnification anatomical preparation from a histological perspective. The intrinsic contrast provided by air in HRCT enables the identification of even the subtlest morphological changes in the lung tissue. By interpreting the findings observed on HRCT, radiologists can make a differential diagnosis and provide a pattern diagnosis in collaboration with the clinical and functional data. The use of quantitative software and artificial intelligence (AI) further enhances the analysis of ILDs, providing an objective and comprehensive evaluation. The integration of "meta-data" such as demographics, laboratory, genomic, metabolomic, and proteomic data through AI could lead to a more comprehensive clinical and instrumental profiling beyond the human eye's capabilities.

Keywords: AI (artificial intelligence); HRCT (high-resolution computed tomography); ILDs (interstitial lung diseases).

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
(A,B) (image J, Java open source): In (A), a control normal lung is depicted by a sharply shifted Gaussian curve with a narrow and tall peak. In (B), a representative slice of the right lung from a patient with advanced idiopathic pulmonary fibrosis, obtained through thin-section volumetric CT, is shown and illustrates the density histogram of the fibrotic lung, which exhibits a less pronounced peak and skewness compared to panel A. The segmented area of interest is highlighted in yellow. On the right side, the results of the digital processing analysis for this specific slice are presented. Once the sampling of the entire lung was completed, the software automatically generated averaged data from the analysis of all slices of both lungs.
Figure 2
Figure 2
(Slicer3D): UIP/IPF: Color-coded map differentiated for lung areas. Histogram analysis provides an accurate description, both globally and regionally, of mean lung density (MLD), skewness, and kurtosis parameters, with increased potential to stratify fibrotic damage.
Figure 3
Figure 3
High-resolution computed tomography (HRCT) images and regions classified as fibrosis by data-driven texture analysis of a 53-year-old man former smoker: (A) the baseline of fibrosis score was 11.2%; baseline FVC % pred was 73%, DLCO % pred was 69.0%. (B) HRCT images in the same subject at a nominal 78-week follow-up. Regions classified as fibrosis by DTA are shown in orange. The DTA fibrosis score increased by 12.6% percentage points at follow-up. FVC declined 10.5% (relative to baseline), DLCO declined 13.0% (relative to baseline).

References

    1. Raghu G., Remy-Jardin M., Myers J.L., Richeldi L., Ryerson C.J., Lederer D.J., Behr J., Cottin V., Danoff S.K., Morell F., et al. Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline. Am. J. Respir. Crit. Care Med. 2018;198:e44–e68. doi: 10.1164/rccm.201807-1255ST. - DOI - PubMed
    1. Mueller-Mang C., Grosse C., Schmid K., Stiebellehner L., Bankier A.A. What every radiologist should know about idiopathic interstitial pneumonias. Radiographics. 2007;27:595–615. doi: 10.1148/rg.273065130. - DOI - PubMed
    1. Flaherty K.R., Andrei A.-C., King T.E., Jr., Raghu G., Colby T.V., Wells A., Bassily N., Brown K., Bois R.D., Flint A., et al. Idiopathic interstitial pneumonia: Do community and academic physicians agree on diagnosis? Am. J. Respir. Crit. Care Med. 2007;175:1054–1060. doi: 10.1164/rccm.200606-833OC. - DOI - PMC - PubMed
    1. Lynch D.A., Sverzellati N., Travis W.D., Brown K.K., Colby T.V., Galvin J.R. Diagnostic criteria for idiopathic pulmonary fibrosis a Fleischner Society White Paper. Lancet Respir. Med. 2018;6:138–153. doi: 10.1016/S2213-2600(17)30433-2. - DOI - PubMed
    1. Walsh S.L.F., Lederer D.J., Ryerson C.J., Kolb M., Maher T.M., Nusser R. Diagnostic Likelihood Thresholds That Define a Working Diagnosis of Idiopathic Pulmonary Fibrosis. Am. J. Respir. Crit. Care Med. 2019;200:1146–1153. doi: 10.1164/rccm.201903-0493OC. - DOI - PubMed

LinkOut - more resources